A rebound of COVID-19 symptoms in some patients after taking Pfizer's antiviral Paxlovid may be related to a robust immune response rather than a weak one, U.S. government researchers reported on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients treated with etrasimod achieved symptomatic ...

“ The combined radiographic response and symptomatic improvement observed in this patient and the strong correlation with histological data demonstrated the investigational therapy’s intended cellular ...

This program of research is focused the measurement of biobehavioral factors underpinning the perception and response to symptoms among patients with heart failure. The Heart Failure Somatic ...